Nano-Biotechnology
Antibacterial silver nanoparticles: effects on bacterial nucleic acids

Mehran Alavi; Michael R. Hamblin

Volume 3, Issue 1 , March 2023, , Pages 35-40

https://doi.org/10.55705/cmbr.2022.361677.1065

Abstract
  Various microorganisms are located on the human skin, mucous membrane and inside the human body. Many of these microorganisms are beneficial and few are even essential, however, some pathogens are known to cause infection and have the ability to attack and damage the host tissue. Treatment of infectious ...  Read More

Antibacterial silver nanoparticles: effects on bacterial nucleic acids


Nano-Biotechnology
The efficiency of metal, metal oxide, and metalloid nanoparticles against cancer cells and bacterial pathogens: different mechanisms of action

Mehran Alavi; Mahendra Rai; Fleming Martinez; Danial Kahrizi; Haroon Khan; Irwin Rose Alencar de Menezes; Henrique Douglas Melo Coutinho; José Galberto Martins Costa

Volume 2, Issue 1 , March 2022, , Pages 10-21

https://doi.org/10.55705/cmbr.2022.147090.1023

Abstract
  The applications of nanoparticles in various practical fields, owing to their unique properties compared with bulk materials, have been occupying the minds of scientists for several decades. In this regard, a combination of pharmacology and nanotechnology has contributed to producing newer effective ...  Read More

The efficiency of metal, metal oxide, and metalloid nanoparticles against cancer cells and bacterial pathogens: different mechanisms of action


Nano-Biotechnology
Antisense RNA, the modified CRISPR-Cas9, and metal/metal oxide nanoparticles to inactivate pathogenic bacteria

Mehran Alavi; Mahendra Rai

Volume 1, Issue 2 , August 2021, , Pages 52-59

https://doi.org/10.55705/cmbr.2021.142436.1014

Abstract
  Finding efficient therapeutic strategies to fight antibiotic-resistant bacteria is a complicated affair specifically in the therapy of chronic bacterial infections related to hospital-acquired infections. Recently, three major antibacterial systems based on antisense RNA, CRISPR-Cas9, and metal/metal ...  Read More

Antisense RNA, the modified CRISPR-Cas9, and metal/metal oxide nanoparticles to inactivate pathogenic bacteria